Xilio Therapeutics, Inc. (XLO)
NASDAQ: XLO · Real-Time Price · USD
8.01
+0.70 (9.58%)
At close: Oct 27, 2026, 4:00 PM EDT
8.00
-0.01 (-0.12%)
After-hours: Oct 27, 2026, 7:30 PM EDT
Xilio Therapeutics Employees
Xilio Therapeutics had 76 employees as of December 31, 2025. The number of employees increased by 12 or 18.75% compared to the previous year. That makes Xilio Therapeutics the 33,011th largest employer in the world and 4,318th in the United States.
Employees
76
Change (1Y)
12
Growth (1Y)
18.75%
Revenue / Employee
$843,316
Profits / Employee
-$287,224
Market Cap
52.71M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 76 | 12 | 18.75% |
| Dec 31, 2024 | 64 | -9 | -12.33% |
| Mar 31, 2024 | 56 | -33 | -37.08% |
| Dec 31, 2023 | 73 | -16 | -17.98% |
| Sep 30, 2023 | 81 | -8 | -8.99% |
| Jun 30, 2023 | 84 | 6 | 7.69% |
| Mar 31, 2023 | 89 | 11 | 14.10% |
| Dec 31, 2022 | 89 | 15 | 20.27% |
| Mar 31, 2022 | 78 | 21 | 36.84% |
| Dec 31, 2021 | 74 | 17 | 29.82% |
| Sep 30, 2021 | 69 | - | - |
| Jun 30, 2021 | 66 | - | - |
| Mar 31, 2021 | 57 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Caribou Biosciences | 97 |
| Pliant Therapeutics | 49 |
| Mereo BioPharma Group | 39 |
| Biomea Fusion | 37 |
| Elicio Therapeutics | 33 |
| iBio, Inc. | 23 |
| Gain Therapeutics | 21 |
| ImageneBio | 18 |
XLO News
- 1 day ago - Xilio Therapeutics doses first patient in XTX501 trial - TheFly
- 1 day ago - Xilio Therapeutics Announces First Patient Dosed in Phase 1/2 Clinical Trial of XTX501 in Patients with Metastatic NSCLC - GlobeNewsWire
- 6 days ago - Xilio Therapeutics initiated with an Outperform at Raymond James - TheFly
- 25 days ago - Xilio Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 4 weeks ago - Xilio Therapeutics appoints Houvras as chief medical officer - TheFly
- 4 weeks ago - Xilio Therapeutics Appoints Yariv J. Houvras, M.D. - GlobeNewsWire
- 2 months ago - Xilio Therapeutics Reports Second Quarter 2026 Financial Results and Provides Pipeline and Business Updates - GlobeNewsWire
- 2 months ago - Xilio Therapeutics Earnings release: Q2 2026 - Filings